Monday, January 31, 2011

Too many PhDs? C&EN's Beth Halford tackles the question

Remind you of your committee?
Photo credit: AtixVector
Bethany Halford's long-awaited article on the "PhD glut" came out last night; it's a doozy, so you should just go over there and read it right now. I'll wait here.

Read it? Great -- here are my thoughts:

The Good: 
  • The statistics are basically inarguable and finally collected all in one place. Supply is going up, demand as measured by starting Ph.D. salaries has gone down by 1% between 1998 and 2009. Basically static demand, while the supply has continued to go up. 
  • The quotes from Prof. Michael Doyle ("Synthetic organic chemistry, process development chemistry, and medicinal chemistry have been severely affected by the downturn in the economy and the lack of jobs in the pharmaceutical industry.") and Prof. Amir Hoveyda ("Some people in organic chemistry have been very strongly gearing what they do in their programs toward what pharma needs,"). I sincerely hope that this will cause some amount of rethinking on the part of the academic community.
The Bad:
  • The quote from the biotech CSO at the end of the article: “We really aren’t training too many Ph.D.s for the jobs available. I think people just need to look outside the realm of chemistry research and start thinking about things that still involve chemistry and use the tools that you learned in graduate school but that aren’t necessarily bench-type jobs." O RLY? So what you're saying is that we're training too many Ph.D. chemists just as long as they want to be chemists. Oh, okay. 
  • The number of PhD-granting graduate school is 196 in the US. Does anyone think we'll be okay if we cut that number down to, say, 170? Or 150? Or 96?
  • The quote from the biomedical prof (Juliano) is telling, too. Ph.D. scientists going into regulatory affairs? Hey, you don't need a Ph.D. to do that...
The Ugly:
  • There's a physical chemistry Ph.D. who applied for a bunch of nanotech positions only to get turned down. That's not good for anyone; they're supposed to be the next thing after pharma. Uh-oh....
  • The quote from Professor Platz ("For 30 years, I’ve been telling young people that the only reason they should go to graduate school in chemistry or any field of science is because they have a calling to learn that field of science—the way someone has a calling for art, music, or the priesthood... You should only do it for that sense of love and personal fulfillment. It’s very hard to predict a job market five years hence.”) If this is true, there are a whole lot of people in graduate school who are there for the wrong reason. If this is true, the government should not be paying for many of these positions. If this is true, we're all doomed (a little.)
If you're a skeptic on the Ph.D. glut, you have to be able to refute the statistics at the beginning of the article or you have to be hoping for a big turnaround sometime soon. Finally, it's my contention that every single 1st year graduate student in chemistry should be required to read this article. Huge kudos to C&EN's Beth Halford for a really thorough and excellent article.  

Friday, January 28, 2011

20 ways to say "I don't know."

As opposed to the pleasure felt by telling someone that "they're wrong", there's always a little sting in answering a question about your project or your science by saying "I don't know." Here's a few ways of saying those 3 unpleasant words:

1. [single shoulder shrug]
2. Let me check on that.
3. That's a really good question.
4. So this is really preliminary data, but we felt that it was important that we get this out there first...
5. Hmmmmmmmmmmmmmm.................
6. Look at the time! Gotta go!
7. [hands outstretched, palms up]
8. Here's the NMR, Professor Sames!
9. [Eyes narrowed] Did (insert hated rival's name) put you up to this?
10. I think that's in my lab notebook.
11. I haven't looked at that yet.
12. The literature doesn't really speak to that.
13. But, it's obviously the thermodynamic product!
14. [double shoulder shrug]
15. You know, that's something we're going to look at in our next round of experiments.
16. [silence] Any other questions?
17. IDK my BFF Jill?
18. Huh.
19. You know, there are some questions that we haven't been able to answer.
20. I don't know.*

*(Only to be used in dire circumstances or if you have a sudden attack of extreme honesty.)

Where to go from here?


Hey, Bessie, you're looking tasty...
Photo credit: cleantech.com
The news of layoffs at Abbott is certainly hard to take; even though we should all be inured to the constant drumbeat of news about job cutting at big pharma companies, (to me) it is still really hard to take. Each job lost is an affected human being, a family put under stress and coworkers with (potentially) survivor's guilt and sadness in their hearts.

Over at "In the Pipeline", entropyGain makes an interesting set of suggestions for moving forward and a prediction about pharma job growth:
Clearly, it is more difficult than ever to succeed as a drug-hunter in larger companies, and if we do, we usually remain a dairy cow -- fed enough to make some milk but slaughtered when the investors need a little earnings meat. Startups may not be any easier - undercapitalized, underresourced-- hunting with bow's and arrows again, starving often but eating what we kill.
So what can we as scientists do to help our industry? Maybe a little more public service and consideration for our peers. Accept that request to review a journal article or sit on a study section - don't let that crap get in the journals or get funded. Cut some slack to the startup pitching your BD [CJ's note: business development] group when you sit on the diligence team. Look hard at the data they have and try not to let your company spend hundreds of millions on red wine extract, but if that little startup doesn't have chronic data from your favorite 4 animal models, and yet the molecule is good, maybe you can help BD find a way to structure a deal to get the data and collaborate. When a restructuring does happen and there's ton's of unused "junk" lying around -- find a way to get it to the local startup community. We live on that "junk" a lot of the time.
One thing is for sure, domestic job growth for scientists will only come from small companies for the foreseeable future.
It is difficult for me (as a relative novice) to know if eG's ideas are good or not; certainly, the attitude of a typical BD group is "show us what you got" and not "sure, we can help you" and rightly so. That being said, I don't really see job growth coming from the big companies anytime soon. Let's hope he's right that there is some to be had, somewhere.

Thursday, January 27, 2011

Quote of the week: why micromanagement is bad

Once again, from Lt. Gen. Gus Pagonis and his book:
I never tell a subordinate how to carry out a specific goal. Dictating terms to a subordinate undermines innovation, decreases the subordinate’s willingness to take responsibility for his or her actions, increases the potential for suboptimization of resources, and increases the chances that the command will be dysfunctional if circumstances change dramatically. Our first month in the theater only underscored my sense that our team would have to be incredibly elastic. [emphasis CJ's]
The last time I talked about my issues with micromanagement, I got a little pushback* from the academic side, where people are younger and less experienced (and safety issues may exist). So I'll say up front, this applies less to school than to the working world; this also applies less to the relationship between a supervisor and a novice versus the relationship of two similarly experienced people.

But it's that second clause that I find most telling -- when you tell someone what to do, they're much less to look into the details of what they're doing ('I just did what you told me to.') Far better to allow people the room to make their own decisions and allow them the freedom to innovate and grow.

*perfectly reasonable, I might add.

Daily Pump Trap: 1/27/11 edition

Good morning! Between January 25 and January 26, there are 11 new positions posted on the ACS Careers website. Of these, 5 (45%) are academically connected.

Food: Silgan White Cap (Downers Grove, IL) desires a M.S. polymer chemist to "[d]evelop new raw materials for food closures - gaskets, resins, coatings. Work with manufacturing facilities to run manufacturing trials and solve closure manufacturing issues related to raw materials." Takes all kinds...

Multi-level chemistry?: Herbalife International (Torrance, CA) is looking for a B.S./M.S. analytical chemist with experience with method development and compliance with cGMP requirements.

Plastics: Henkel (Rocky Hill, CT) is looking for a Ph.D. chemical engineer for a scale-up position from lab to pilot plant. It's titled as a "chemist" position, but they're also saying things about "unit operations" -- that's ChemE talk.

Well, that's interesting: The Louisiana School for Math, Science, and the Arts is a residential high school in Natchitoches, Louisiana; they're looking for a M.S./Ph.D. chemist, biochemist or engineer to teach and direct high school research. Looks like industrial experience might be a plus -- huh.

So's this: Sapling Learning is an online teaching company; they're looking for a M.S./Ph.D. chemist for a chemistry/physics specialist. As much as I think the recent push for online learning and non-traditional universities are being run by charlatans (I'm looking at you, Kaplan University), this is undoubtedly real and a wave of the future.

Wednesday, January 26, 2011

PTFE O-rings

Not much time to blog this morning, but some small useful things (links):

Tuesday, January 25, 2011

Interview: Lab Monkey, analyst of the UK chemistry jobs market

Imagine my surprise when I got an e-mail from Lab Monkey, suggesting that I look at LM's new blog, LabMonkey4Hire. It is an analysis of the chemistry job market in the UK. (Personally, I really like the occasional focus on a job category -- it's something I might copy!) Below is an e-mail Q&A with Lab Monkey; the answers were briefly edited by CJ and checked for accuracy by LM.

CJ: Can you tell me a little about your background?

LM: I graduated as a chemist around 10 years ago, worked in a couple of relatively small companies - earning not much money but having a great time - before the lure of untold wealth and benefits attracted me to the world of pharmaceuticals. I'm still chasing the rainbow to find the pot of gold :-)

CJ: What has the last few years been like for chemists in the UK and in Europe?

LM: Traditional bench chemistry feels like a career in decline in the UK - the boom years of the 90's have well and truly passed. In the early 2000's, medium and large sized chemical companies still had annual recruitment drives for graduates - the jobs section in New Scientist was packed - but now you have to do a lot more digging. While most larger companies have had recruitment freezes for a few years now (and in some industries made massive cuts), the smaller CROs appear to be surviving with their lower cost structure (and salaries) - as they pick up outsourcing from the larger ones. I think Europe has been seeing similar trends as the non-EU parent companies shift their manufacturing and R&D elsewhere. Interesting anecdote though - we've had a large French chemist population in the UK for a long time due to the even worse prospects there, but a lot of them seem to have been heading back to France recently...

CJ: What is the state of pharma in the UK?

LM: Pharma has had a difficult 3-4 years in the UK - with widespread site closures and bouts of redundancies. Of the top 10 pharma companies in the UK - all common names - most if not all have been affected.

CJ: How is finding a job different in the UK than in the US?

LM: I guess we have the same basic process - regularly checking sites like NewScientistJobs and Monster, sending off CVs, wondering whether the agency will ever get back to you. I wonder though whether networking is easier in the UK, and "they" say that's the future of recruitment. As we're a small country and industry tends to be concentrated in a few key locations, you fairly quickly build up a network throughout industry from university, various jobs, conferences, vendors, service engineers, etc. LinkedIn is making this even easier - it keeps people on your radar - but I don't think it's reached its potential yet. The other advantage of being a small nation is it's fairly easy to move, and family/friends are usually no more than a few hours drive away.

CJ: Do you see things getting better or worse in the next year?

LM: I think we may have a bit of a breather in 2011. The recent cuts need a bit of time to work themselves out, which will hopefully buy us 12-18 months stability in R&D. With advances in new technologies and green energy, I'd really love to see an explosion of start-ups to take on entrepreneurial chemists looking for high risk/high reward jobs.

CJ: Anything else you'd like to say to the CJ readership?

LM: Only that if you'd like more info on the UK jobs market, please join me at labmonkey4hire.blogspot.com. It's been heavily inspired by Chemjobber's format of regular highlights from the jobs boards; and hopefully will evolve with related news in the near future.

[CJ here again]. Just like he says, if you're interested in the job market for chemists in the UK, head over there! Thanks to LM for the great Q&A!

Jobs at the Central Intelligence Agency

A knowledgeable person writes with some comments about openings at the Turner-Fairbank Highway Research Center Central Intelligence Agency:

Science, Technology, and Weapons Analyst: "This is listed in the “Special Opportunities” group – very suggestive of a priority. My educated guess is that this posting is for multiple hires. This type of position is where you’d be answering the Elbonia black phosphorus type questions in the recent post. Specifically, this would be in CIA’s Directorate of Intelligence."

Technical/Targeting Analyst: "This position is very much a step in the direction of what you see on television, i.e., real “spook” work. There is a definite S&T component to this position category. Probably multiple positions."

Research Scientist: "Almost certainly for positions with CIA’s Directorate of Science and Technology. The chances of you actually doing any lab work are about 1 in a 1000. This job category will have fewer hires than the [other] positions."

Many thanks to our helpful insider and best wishes for our job seekers.

Daily Pump Trap: 1/25/11 edition

Good morning! Between January 20 and January 24, there were 35 new positions posted on the ACS Careers website. Of these, 15 (43%) are academically connected and 1 (3%) are from our friends at Kelly Scientific Resources.

Butte, MT: Resodyn Corporation is a stalwart of the ACS Careers board; they've been advertising positions for chemists since 2008, it seems. Anyway, they're looking for a Ph.D. polymer chemist / materials scientist with 5+ years in the coating industry.

Trenton, NJ: Redpoint Bio is looking for two M.S./Ph.D. medicinal chemists to perform research towards curing diabetes.

Houston, TX: Total Petrochemicals (the French oil giant) has two positions, a plant support position (Ph.D. chemist) and a catalyst group Ph.D.

Lexington, MA: You know, sometimes a job posting is smarter than I am. Here's the description for RainDance Technologies: "The core RainStorm™ technology empowers customers to conduct de novo science in an ultra high throughput, simple, flexible, and low cost manner. RainDance’s commercial products include instruments and high-value consumables and reagents for sequence enrichment for next-generation sequencing, ultra-deep sequencing, and methylation analysis." Oh, okay. They're looking for a Ph.D. synthetic/polymer chemist who can work on fluorinated block copolymers for their core technology. Actually, sounds pretty interesting.

Good on ya: Kelly's one position is quite relevant. I like it.

Monday, January 24, 2011

The plural of paltry is not "far from stagnant"

From the January 24 issue of Chemical and Engineering News, a sidebar from an article on liberal arts teaching positions:
Chemists Wanted
The job market for liberal arts faculty positions is far from stagnant. For example, Simmons College is in the midst of a faculty search for a physical or biophysical chemist with strengths in instrumentation. Claremont McKenna College is currently seeking a biochemist, a molecular biologist, and a climate scientist. An organic chemist is retiring from Haverford College, which will most likely mean a job opening in the coming year. The chemistry department at Bowdoin College is seeking approval to hire two new physical organic chemists in 2011. And the chemistry department at Drew University recently advertised a two-year position for a visiting professor in organic chemistry.
I find this paragraph a little irritating, but I can't quite put my finger on it. I think it's the context-less statement that the job market for liberal arts faculty positions is "far from stagnant" -- what does that even mean? In that there's a fair number of positions, sure, that might be a reasonable position. In the practical sense that the average chemist could potentially attain one of these positions, that's most certainly not the case. The competition for teaching jobs is too fierce for words. I can't quite tell what the writer is trying to say, but I'm pretty sure that I disagree with them.

The comment on the Haverford College retirement is (in my arrogant opinion) naive at best; there's no telling what the faculty and administration will do. The Bowdoin College position hasn't appeared yet -- no ads. (Right? Wait, let me check... nope! It's not on their faculty hiring page.) The position at Drew is on the Wheel of Pain -- I'm not sure we want to count that.

Nice try, folks. Sorry to burst your bubble.

Friday, January 21, 2011

Sometimes it feels this way

Photo credit/source: Aquabotic.com
Apologies to Tina Turner, thanks to Anon011920110455p.

San Diego Job Market Update, Feb. 2010 to current


As some may remember, I have an occasional series where I look at the San Diego job market for chemists by looking at the number of job ads in the San Diego regional ACS newsletter. While not perfectly diagnostic, it is one means of measuring whether or not the job market is improving. From the most recent data (November 2010 through February 2011), things don't look great.

That being said, I have my typical caveats about this measurement: 1) the deep of winter doesn't seem to be a prime time for employers to look for employees, 2) while the ACS Newsletter has (in the past) been a traditional place for San Diego biotechs to look for chemists, they could be going elsewhere and 3) this sort of decline could be cyclical or secular, and we just don't know.

Thursday, January 20, 2011

Standing up: the secret to a good meeting?

You can't do this very long.
Photo credit: scratch.mit.edu
Derek Lowe's post yesterday about the tradition of useless dog-and-pony-show meetings drew a number of interesting comments. Apart from comments about the banning of Powerpoint (potentially contributed to by me) and the people who just don't go, there were a number of comments about removing the chairs, quoted below:
Anon: Perhaps if we removed the chairs from the room and turned off the Heat/AC it mights shorten the show.
Robert Bruce Thompson: Best way I know is to get rid of the conference room table and chairs.
And something slightly more meaty, from Fraxas:
Software development, as a discipline, has had the 'Agile' buzzword sweep through in an attempt to reduce (among other things) this kind of administrative overhead. Specifically, the idea of a *daily* in-team stand-up meeting where everyone says (1) what they're doing (2) what they're having problems with. Every team holds a stand-up, and every few days the leads of those teams hold their own metastandup. Slides and so on are not allowed; any sub-discussion that's not interesting to the whole team or that's taking more than 2-3 minutes is tabled for a different, one-off meeting.
I found this comment interesting, because it reminded me of a passage from "Moving Mountains", by Lt. Gen. "Gus" Pagonis, USA (Ret.); in this book, he describes the logistical thinking behind the 1991 Gulf War.* In his "Building Blocks of Leadership" chapter, Pagonis suggests exactly the same meeting that Fraxas describes. To summarze Pagonis's style, I've laid out his strategy below:
  • It is held every morning
  • Anyone (regardless of rank) is welcome to attend
    • Used to reinforce "free-and-open exchange of information within the command"
    • One representative of "each specialized function" (usually commanding officer) required
  • Everyone is required to stand 
    • Only Pagonis and his note-taker sit
    • Starts precisely on time, ends no later than 30 minutes
  • No agenda
    • Originally for quick status reports and clarifying questions
    • Depending on the week and the most relevant challenges, different groups' concerns would be dominant
Pagonis describes why the stand-up is effective:
Early on, I discovered that making people stand up keeps the ball moving at a quicker pace. People speak their piece and then quickly yield the floor to the next person. On the rare occasion that someone starts to get long winded or wax philosophic, an unmistakable kind of body language begins to sweep through the crowd. People shift from foot to foot, fidget, look at their watches -- and pretty quickly, the conversation comes back into focus. It's an interesting phenomenon. I can't recall the last time I had to crack the whip. The peer group has great power.
Communications flowed in every direction, including some unexpected ones... once it became apparent that certain people could always be found at the stand-up, other people began attending the meeting to catch up with those individuals.
I don't think Pagonis' stand-up model would be particularly effective in a long-term month-to-month progress report manner; also, I think this model wouldn't work well in an environment where medium to long-term research concerns were most important. However, for a small day-to-day research/production atmosphere, I suspect that the stand-up meeting would probably keep everyone well-informed.

*I told you I was going to buy it!

Daily Pump Trap: 1/20/11 edition

Good morning! Between January 18 and January 19, there are 13 new positions posted on the ACS Careers database. Of these, 3 (23%) are academically connected.

The miracles of science: DuPont (Fayetteville, NC) is looking for a Ph.D. analytical chemist, with a breadth of instrumental experience (GC/FID, FTIR, Karl Fischer, XRF, UV/Vis, Instron) to serve as a Principal Investigator. You'll be working on Glass Laminating Solutions; strong project management skills and a Six Sigma (I assume) green belt are desired.

Another Carolina day: GTI Chemical Solutions in Greenville, South Carolina desires a Ph.D. organic/polymer chemist to serve as a Head Chemist. This company is in the polymer business, with positions in the paint and coatings, adhesives, energy and textile markets.

And there's a new title: Agrium is a retail supplier of agrochemicals. They're looking for a B.S. chemist for a position as a "product stewardship manager." 8-10 years business experience, minimum of 5 years as a manager in the fertilizer industry or chemical manufacturing.

Rolla, MO: Brewer Science is a supplier of specialty coatings to the microelectronics industry; they are seeking a M.S./Ph.D. organic chemist to perform research and potentially lead a team.

DFW: Chemguard is looking for a B.S. chemist to perform regulatory compliance duties. You will be "Responsible for all regulatory compliance for the Fire Suppression and Specialty Chemical Divisions. Duties include new product registration, preparation and maintenance of product safety documentation, regulatory agency review and approvals for new products, site-wide federal, state and local regulatory compliance."

Wednesday, January 19, 2011

15 ways to say "You're wrong."

Let's be honest, folks -- sometimes, there's nothing more satisfying than telling a colleague or (better yet) a superior that they might be incorrect. Here are a few ways of passing along that, well, they're wrong:

1. "Hey, uh, did you check that with the literature?"
2. "Horsepucky!"
3. "Do you mind if I see that NMR?"
4. "Huh."
5. "Right!" [walks quickly away]
6. "That's an interesting interpretation -- do you mind walking me through your logic?"
7. "Really?" [arched eyebrow]
8. "The hell it is."
9. "Is there precedent for that?"
10. "%$%$%$$%!"
11. "Whatever you say, Bengu."
12. "You're so full of it, your eyes are turning brown."
13. "Perhaps you need to reinterpret your data."
14. [silence]
15. "I think you're wrong."

Process Wednesday: Stirring during scale-up conditions

Once again, from our friend Neal Anderson:
The motion of the vessel contents is influenced by the agitator and any baffles. The agitator, or impeller, provides the power to move the vessel contents. There are two types of impellers: radial-flow impellers, which move the liquids along the radius of the impeller, and axial-flow impellers, which move the liquids parallel to the axis of the agitator shaft. Without baffles, low-viscosity fluids tend to create vortices and swirl with poor mixing; baffles disrupt vortices and promote flow patters that lead to good mixing. With baffles in place either radial-flow or axial-flow agitators can provide good mixing for most chemical operations used in the chemical processing industry.1

[later] Rapid distribution of reaction components does not take place on scale in conventional stirred reactors. For instance, based on pH measurement it may take 3-5 minutes for a reagent added at the top of a 500-gallon vessel to be evenly distributed throughout the solution. Mixing can be described as macromolecular mixing, which relates to the average composition of the vessel contents, and as micromolecular mixing, which considers the contacts of molecules on a molecular basis and any gradients that may result.2 Suitable micromolecular mixing can be difficult to perform on scale.
I confess that I didn't really know what a baffle was until this morning, when I saw the Wikipedia diagram. On the mixing front (pun?), this is something that I've seen, but not on the scale that Anderson refers to. Unsurpringly, agitation is something that is difficult, even on a scale as small as a 22-liter flask.

1. Oldshue, J.Y. Fluid Mixing Technology; McGraw-Hill: New York; 1983, 12-18.
2. Genck, W.J., "Crystallization's Forgotten Facet." Chem. Eng. 1997, 104(10), 94.

Tuesday, January 18, 2011

Chemophobia and you

I'm reading a lot of the washup posts from ScienceOnline 2011 (gotta get tickets/registered for #scio12; it's like trying to get tickets for The Police reunion concert or something) and I saw this post on uh, the 'baloney' filter that people need:
Be skeptical of skeptics, Reuters Health Executive Editor Ivan Oransky urged a standing-room-only crowd at what was called a "keepers of the bulls**t filter" session.
His tips apply to all consumers and producers of science, health and medical information: keep a biostatistician in your pocket (that is, call on experts to assess the stats you read in research reports); understand the limits of the review procedures used to decide what is published in a journal; avoid disease mongering, the expansion of disease definitions in order to promote unnecessary treatments.
I agree wholeheartedly with Oransky about the need for a clear-eyed scientific outlook when you're considering new medical information, especially when it comes from popular media sources. [So is Reuters Health basically responsible for all the stories on the news at 10:13 (or 11:13) pm that say things like "Is pizza responsible for your impotence? Find out next, after this break."]

My personal hobbyhorse is chemophobia, i.e. the blaming of bad "molecules of the moment" for whatever bugaboo disease is around. For a wonderful example, check out this comment (from Oransky's blog!) about what causes autism:
"Without being a conspiracy theorist, I have wondered if the vaccine scare was funded by firms that have a vested interest in preventing epidemiological or clinical evidence from emerging about their products, like pesticide makers. Cigarette companies certainly spent decades funding groups to try to push the blame elsewhere, and continue to use money to sell story that cigarettes aren’t a significant contributor to cancer and lung disease.

The realist in me says, though, that the millions of synthetic chemicals to which we are exposed constantly in food, water, and air in unexpected and untested combinations likely are part of the root of all kinds of health issues."
$#$#$#^%%$#%$#! Now we're just fishing: pesticides, cigarettes, synthetics. While I'm as big a fan of the precautionary principle as the next guy, I think these statement are just about as scientific as blaming yesterday's bad reaction on demons. Why, the temperature probe read 66.6°C!

If I were to offer some things to keep in mind, here they are:
  1. Dose makes the poison
  2. S--t happens; you're going to die of something.
  3. I don't know what caused your cancer and neither do you (except your cigarettes, maybe.)
  4. Your liver is really, really good at removing things that don't belong in your body. (Yes, sometimes the metabolites can be the issue themselves.)
  5. If you hear the terms "millions of synthetic chemicals", "toxins" or "body burden" or any of the other weasel words, the person is punting.
  6. Listing acute MSDS symptoms is a scare tactic. I'm looking at you, Environmental Working Group.
  7. A molecular mechanism is the start of good science on the effects of chemicals on the body; an epidemiological study is the start of a media scare.
  8. Dose makes the poison.
Readers, doubtless I'm getting carried away here. Tell me I'm wrong in the comments. (Or list your chemophobia warning signs.)

Halcyon Molecular, a Bay Area biotech, seeks chemists

I've been contacted by a representative of Halcyon Molecular, the company that I posted about earlier. They're looking for some synthetic chemists and an analytical chemist as well. While they will be looking for Bay Area chemists first, they're willing to consider chemists out of the area (relocation package is possible.) "High competence" and "thoroughness" is among the top things they're looking for.

If you have specific questions, leave them in the comments or e-mail me -- I'll be forwarding them to my contact.

Research Scientist — Synthetic Chemistry, Research & Development, Redwood City, CA, United States

Halcyon Molecular is a growing team of 40 scientists and engineers working to transform biology into an information science. Current gene sequencing methods are too slow, too expensive, and too incomplete to make "personalized medicine" more than a buzzword.
We are currently looking to hire synthetic chemists with one to ten years of post-graduate experience. Candidates with prior experience preparing metal clusters, small nanoparticles, and organotransition metal complexes may be especially well suited.

The successful candidate will:
  • have a M.S. or Ph.D. in Chemistry or a related field
  • be proficient with laboratory scale preparative chromatography and all the usual spectroscopic techniques
  • have 1-10 years of post-graduate lab experience
  • be collegial, cooperative, and have a proactive work ethic
Research Scientist — Analytical Chemistry, Research & Development, Redwood City, CA, United States
Requirements:

An experienced analytical chemist with a broad knowledge and significant hands-on experience using various analytical chemistry tools, especially HPLC and CE. Primary responsibilities include: analytical method development; characterization of assay products; measuring reaction kinetics; determining reaction selectivity and specificity; optimization of running conditions for novel compounds; and communication across functional areas.

The successful candidate will:
  • develop quantitative methods for the detection of chemical modifications of DNA utilizing capillary electrophoresis
  • demonstrate broad expertise in various analytical methods including CE and HPLC, mass spectrometry is also desirable
  • exhibit resourcefulness and proactive problem-solving
  • have earned a MS or PhD in chemistry, biochemistry, or a related discipline with an emphasis in analytical chemistry

Daily Pump Trap: 1/18/11 edition

Good morning! Between January 13 and January 17, there were 37 new positions posted on the ACS Careers website. Of these, 21 (57%) are academically connected.

Multiples!: Always like a multiple post. Vertex weighs in with more temp positions, Biogen Idec and Cambridge Major do as well. Good news.

Chew on this: The Wrigley Company is looking for an experienced Ph.D. organic/polymer chemist; you'll be working " primarily in the area of new matrix material development and will be an important subject matter expert for existing matrix systems." So new gum?

The desert: Jacobs Technology is a contractor for Dugway Proving Ground, a military test facility in Utah. They're looking for two analytical chemists. Enjoy!

The miracle?: HEC Pharma is a new drug discovery company based "in the miracle city of Shenzhen in China" is looking for pharma scientists of all kinds. I've never been to Shenzhen, but I'm guessing that miracle is not one of the words a typical Westerner would use. Remarkable, certainly. Miracle? Hmmmmmm.

Monday, January 17, 2011

Why is Elbonia working on black phosphorus?


I made a comment the other day about the difficulty in understanding US government job postings, especially in the defense area. I talked with a knowledgeable person; here is part of our conversation:


CJ: I understand what the Defense Intelligence Agency does (I think) -- why do they need scientists? What is the chance that a Ph.D. chemist might get one of these positions?

Having some familiarity with DIA, I’m going to assume that one of the 15 slots in this posting is to cover the chemical “threat”.  That said, I’ll make the educated guess that a Ph.D. chemist coming right out of a post-doc position would have a 1 in 10 chance of being selected relative to a BS or MS person. Why is this?  DIA is a military intelligence organization and as such, it likes…no, demands, that individuals subsume their opinions for the good of the team. While DIA would hire a PhD-level senior scientist from within the DOD or Intelligence community for a senior-level slot, my educated sense is that this isn’t what DIA is after.

DIA and other intelligence and law enforcement agencies need scientists to assist in interpretation of intelligence reporting, e.g.,  Why is Elbonia working on black phosphorus?  What are the strategic goals of Narnia’s Defense Science and Technology Agency?  What is the probability that Atlantis’ program to develop non-RE alternatives to Rare Earths (RE) will be successful? Based on kilo-lab production capabilities reported two year ago, what is this likelihood that Lilliputia will develop a world-scale production process for its revolutionary new explosive, selenous boomboom?


CJ: If you search under "chemist" on USAJOBS.gov, you'll get a lot of posting for "chemist (acquisition)" for the Department of the Navy. What are these postings about?

The answer is in one of those Navy postings: "The Duncan Hunter National Defense Authorization Act (NDAA) FY 2009 provides that the Secretary of Defense can designate acquisition positions within the Department of Defense as shortage positions and recruit and appoint highly qualified persons to those positions."

What this means is the following:  The US Government is increasingly having difficulty in finding and retaining experienced personnel to manage acquisitions. Government acquisition regulations and processes are insanely complex and the pay that formal acquisition people get isn’t all that great. The huge number of experienced acquisition people retiring hasn’t been matched by new hires…therefore…what Duncan Hunter says is that the Department of Defense (maybe other agencies too) can hire you as a scientist and assign you to do acquisition grunt work. The downside is that PhD training in chemistry isn’t going to be remotely relevant to whatever it is that you’re responsible for with your acquisition duties; the upside is that if you’re in need of a job, acquisition is a place that you can look forward to immense job security.


CJ here again. An interesting bit of information, especially for those of us who might be contemplating working for the federal government. Best wishes to all the federal job seekers and many thanks to our knowledgeable insider.